Diligence memo · auto-generated · as of July 2, 2026
Synthesis Health Inc.
Synthesis Health Inc. looks under-valued against its niche peers and is active on financing cadence.
Businessfiled
Synthesis Health Inc. operates in Healthtech, based in VANCOUVER.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Synthesis Health Inc. has raised $11M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $9.5M on 2024-05-10.
Most recent recorded round closed around 2025-07-25.
Valuation (modeled)modeled
Provath models Synthesis Health Inc. at approximately $6.1M (range $2.3M–$10M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.32× the median modeled value of Series A Healthtech companies in 2025–2027 (99 peers) — value vs value, same stage and era. Issuer reports $5M–$25M revenue while modeled below niche peers.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 11 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 5.2× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 72% of Healthtech peers (2138 compared).
Modeled value ranks above 26% of those peers.
Closest niche peers: Queen Dental USA Inc, Healthplan Data Solutions, Inc., Chronic Care Management, Inc., Mountain Health Technologies, Inc., Modular Medical, Inc..
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.